Skip to main content

DMK Pharmaceuticals Corp

DMKDelisted Mar 21, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000887247

DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding DMK Pharmaceuticals Corp changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of DMK: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders4946−3
Shares14.2M12.9M−1.26M (−8.9%)
Value$8.58M$7.38M−$1.20M (−14.0%)

New holders (4)

Institutions that held DMK Pharmaceuticals Corp at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to DMK in Q1 2022
InstitutionSharesValue% of portfolio
Capital CS Group, LLC70,513$40.0K0.03%
Atria Wealth Solutions, Inc.15,000$9.00K0.00%
Royal Bank of Canada5,000$3.00K0.00%
Citigroup Inc250$00.00%

Sold out (7)

Institutions that held DMK Pharmaceuticals Corp at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of DMK in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Virtu Financial LLC224,561$136.0K
Millennium Management LLC138,666$84.0K
Atom Investors LP75,209$46.0K
Jane Street Group, LLC41,716$25.0K
Two Sigma Securities, LLC22,906$14.0K
HRT Financial LP21,321$12.0K
Wolverine Trading, LLC14,643$9.00K